Full history for every metric is available with a Kvantra account
Mediclinic International plc (MEI.JO)
Key financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 2,749 | 2,870 | 2,932 | 3,083 | 2,995 | 3,233 | 2,425 |
| Operating profit | £m | 280 | 191 | |||||
| Net profit | £m | 229 | -474 | -130 | -299 | 68 | 151 | 128 |
| EPS reported | £ | 0.21 | 0.17 | |||||
| Operating cashflow per share | £ | 0.75 | 0.75 | |||||
| Capex per share | £ | 0.24 | 0.24 | |||||
| FCF per share | £ | 0.51 | 0.51 | |||||
| Free cash flow | £m | 375 | 281 | |||||
| Net debt | £m | 2,049 | 512 | |||||
| Book value equity | £m | 3,107 | 812 | |||||
| Book value per share | £ | 4.21 | 1.10 | |||||
| Number of shares | m | 737.29 | 736.59 | |||||
| DPS (TTM paid) | £ | 0.03 | 0.00 |
Financial summary
Financials in GBP| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 17.06 | - | |||||
| P/B LTM | x | 0.85 | 493.48 | |||||
| P/S LTM | x | 0.82 | 165.16 | |||||
| P/FCF LTM | x | 7.07 | 1,423.86 | |||||
| EV/EBITDA LTM | x | 9.26 | 1,065.00 | |||||
| EV/Sales LTM | x | 1.46 | 165.37 | |||||
| Earnings Yield LTM | % | 5.86% | 3.82% | |||||
| FCF Yield | % | 14.14% | 0.07% | |||||
| Quality | ||||||||
| ROE | % | 4.86% | 5.07% | |||||
| ROIC | % | 3.44% | 3.44% | |||||
| Operating margin | % | 8.66% | 8.66% | |||||
| Gross margin | % | 15.62% | 15.62% | |||||
| FCF/Sales | % | 11.60% | 11.60% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +128.26% | +112.23% | |||||
| Sales Growth YoY | % | +7.95% | +7.95% | |||||
| Net Income Growth YoY | % | +122.06% | +115.19% | |||||
| FCF Growth | % | +59.57% | +59.57% | |||||
| Operating Profit Growth | % | +100.00% | +63.46% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.14 | 0.43 | |||||
| Net Debt/EBITDA | x | 4.05 | 4.05 | |||||
| EBIT/Net interest | x | 4.52 | 4.52 | |||||
| Net debt/market cap | % | 77.28% | 0.13% | |||||
| Net debt/Equity | x | 0.66 | 0.63 | |||||
| Gross debt/equity | x | 0.83 | 0.80 | |||||
Company overview
Mediclinic International plc is a prominent healthcare provider that, through its various subsidiaries, manages and operates private hospital facilities. Operating under its well-known Mediclinic and Hirslanden brands, the firm delivers a broad spectrum of specialized and comprehensive healthcare services. Its extensive global network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. This network comprises 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, and 2 mental health facilities, which collectively feature 453 operating theatres and approximately 11,538 inpatient beds. Beyond direct patient care, Mediclinic also offers a range of auxiliary and support services, including treasury functions, medical equipment sourcing and procurement, emergency medical response, general management, food and catering, healthcare administration, and debt recovery. Furthermore, the company handles the management of its healthcare personnel and maintains its property portfolio. Its operations also extend to managing intellectual property and engaging in the medical supply and procurement sector. Established in 1983, the company's headquarters are located in Stellenbosch, South Africa.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Mediclinic International plc (MEI.JO)
Mediclinic International plc is a prominent healthcare provider that, through its various subsidiaries, manages and operates private hospital facilities. Operating under its well-known Mediclinic and Hirslanden brands, the firm delivers a broad spectrum of specialized and comprehensive healthcare services. Its extensive global network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. This network comprises 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, and 2 mental health facilities, which collectively feature 453 operating theatres and approximately 11,538 inpatient beds. Beyond direct patient care, Mediclinic also offers a range of auxiliary and support services, including treasury functions, medical equipment sourcing and procurement, emergency medical response, general management, food and catering, healthcare administration, and debt recovery. Furthermore, the company handles the management of its healthcare personnel and maintains its property portfolio. Its operations also extend to managing intellectual property and engaging in the medical supply and procurement sector. Established in 1983, the company's headquarters are located in Stellenbosch, South Africa.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free